Document is current
Any future updates will be listed below
-
Authors
Urlaub, Doris
Zhao, Shuyang
Blank, Norbert
Bergner, Raoul
Claus, Maren
Tretter, Theresa
Lorenz, Hanns-Martin
Watzl, Carsten
Merkt, Wolfgang http://orcid.org/0000-0002-3108-154X
-
Funding
Funding for this research was provided by:
Medizinischen Fakultät Heidelberg, Universität Heidelberg
Stiftung für Krebs und Scharlachforschung
Eva Luise und Horst Köhler Stiftung
Roche
Third Affiliated Hospital of Nantong University
- License Information
-
More Information
Article History
Received: 1 July 2019
Accepted: 8 November 2019
First Online: 11 December 2019
Ethics approval and consent to participate
: The ethics committee of the University of Heidelberg approved this study. Written informed consent was obtained from healthy donors and patients.
: Not applicable.
: WM has received consultancies, speaking fees and/or honoraria from Novartis and Roche (less than 10,000 each). RB has received speaking fees from Roche, Abbvie, BMS, Chugai, Novartis und Vifor (less than 10,000 each). H-ML has received consultancies, speaking fees and/or honoraria from Roche (less than 10,000 each). NB has received speaking fees / honoraria (less than 10,000 each) from Roche, Novartis, SOBI, Abbvie, UCB and Biomol.
